Feature stories
2010
August 05, 2010
New medicines for neglected diseases
Novartis is pioneering medicines for neglected diseases, with institutes focusing solely on diseases for which research was virtually non-existent.
August 05, 2010
Funding future research
Novartis is leading industry efforts to fill a multi-billion-dollar gap in neglected disease R&D funding.
June 23, 2010
Novartis & Citizenship
See Novartis Chairman Daniel Vasella, M.D., discuss the values and principles of the United Nations Global Compact on its 10th anniversary.
June 23, 2010
Living the Global Compact
In a wide-ranging interview, Klaus Leisinger describes how Novartis embodies the principles of the United Nations Global Compact.
June 23, 2010
Environment & Energy
Keith Saveal, Head of Corporate Health, Safety and Environment & Business Continuity, recounts the evolution of the new UN Environmental Stewardship Strategy.
May 21, 2010
CIBA VISION creates mobile 'app' to train healthcare providers
Eye care professionals are benefiting from an innovative new iPhone® application offering “anytime, anywhere” access to high-quality educational resources.
April 23, 2010
April 25 is World Malaria Day
On World Malaria Day, April 25, the international community highlights the campaign to provide effective control of this deadly disease.
April 22, 2010
Seeking a clearer view of multiple sclerosis
People with multiple sclerosis (MS) face devastating uncertainty, not knowing how the disease will progress or disrupt their daily lives. But scientists are developing new diagnostic tools to aid treatment and ease the unpredictability for patients.
February 18, 2010
Innovating beyond the Vaccine: VaxTrak puts value in the hands of patients and families
Novartis Vaccines and Diagnostics (NV&D) has developed a way to help parents, families and vaccine consumers track vaccinations using the iPhone®
January 26, 2010
New products rejuvenate our pharmaceutical portfolio
Just as new medicines are improving the lives of patients fighting serious diseases, success in innovation is rejuvenating the portfolio of Novartis. Recently launched products grew to 16% of net sales for the Pharmaceuticals Division in 2009.
January 22, 2010
Novartis joins urgent relief efforts for victims of earthquake in Haiti
Novartis joins urgent relief efforts for victims of earthquake in Haiti offering aid in the form of financial support to relief organizations and donations of essential medicines.
January 14, 2010
Legal team helps navigate through economic crisis
In times of global financial uncertainty, the Novartis legal team takes an innovative approach – serving as both a protective guardian and a proactive partner to the business.
About Novartis
We provide medicines to treat and prevent diseases, ease suffering and improve quality of life.
Our products
We have a broad healthcare portfolio.
